Javascript must be enabled to continue!
Integrated Cardiorenal Risk in Multimorbidity: Emerging Biomarkers, Prognostic Stratification, and Contemporary Therapeutic Strategies
View through CrossRef
Cardiorenal syndrome represents a complex clinical condition resulting from bidirectional interactions between cardiac and renal dysfunction and is particularly relevant in patients with multimorbidity, in whom heart failure, chronic kidney disease, diabetes mellitus, hypertension, obesity, and vascular disease frequently coexist. This study analyzed current evidence regarding emerging biomarkers, prognostic stratification, and integrated therapeutic approaches in adult patients with cardiorenal syndrome and multimorbidity. A structured integrative review based on the Scientific Method was conducted using contemporary clinical guidelines, scientific statements, randomized controlled trials, observational studies, and biomarker investigations. The analysis focused on conventional parameters and emerging biomarkers associated with glomerular filtration, tubular injury, myocardial stress, inflammation, and fibrosis. Cystatin C showed its greatest relevance as a complementary marker of glomerular function, while NGAL and KIM-1 were predominantly associated with tubular injury. NT-proBNP was mainly related to myocardial stress and congestion, whereas sST2 and galectin-3 provided additional information regarding inflammatory and fibrotic remodeling. Prognostic assessment demonstrated that declining estimated glomerular filtration rate, increased albuminuria, persistent congestion, recurrent heart failure decompensation, biomarker abnormalities, and greater multimorbidity burden were consistently associated with adverse cardiorenal outcomes. Therapeutic evidence from major randomized trials showed that sodium–glucose cotransporter-2 inhibitors significantly reduced major kidney and cardiovascular events across broad chronic kidney disease populations, while finerenone demonstrated complementary renal and cardiovascular benefits in patients with type 2 diabetes and chronic kidney disease. The findings support a transition from isolated organ-based evaluation toward a multidimensional cardiorenal framework integrating renal function, cardiovascular status, metabolic disease, biomarker profiles, and therapeutic response. Emerging biomarkers may improve biological phenotyping but should currently complement rather than replace established clinical variables. Integrated, multidisciplinary management involving internal medicine, cardiology, and nephrology may provide a more coherent approach to risk stratification and individualized treatment in patients with complex cardiorenal disease.
Quality Consulting Instituto de Educación Capacitación y Certificación de México
Title: Integrated Cardiorenal Risk in Multimorbidity: Emerging Biomarkers, Prognostic Stratification, and Contemporary Therapeutic Strategies
Description:
Cardiorenal syndrome represents a complex clinical condition resulting from bidirectional interactions between cardiac and renal dysfunction and is particularly relevant in patients with multimorbidity, in whom heart failure, chronic kidney disease, diabetes mellitus, hypertension, obesity, and vascular disease frequently coexist.
This study analyzed current evidence regarding emerging biomarkers, prognostic stratification, and integrated therapeutic approaches in adult patients with cardiorenal syndrome and multimorbidity.
A structured integrative review based on the Scientific Method was conducted using contemporary clinical guidelines, scientific statements, randomized controlled trials, observational studies, and biomarker investigations.
The analysis focused on conventional parameters and emerging biomarkers associated with glomerular filtration, tubular injury, myocardial stress, inflammation, and fibrosis.
Cystatin C showed its greatest relevance as a complementary marker of glomerular function, while NGAL and KIM-1 were predominantly associated with tubular injury.
NT-proBNP was mainly related to myocardial stress and congestion, whereas sST2 and galectin-3 provided additional information regarding inflammatory and fibrotic remodeling.
Prognostic assessment demonstrated that declining estimated glomerular filtration rate, increased albuminuria, persistent congestion, recurrent heart failure decompensation, biomarker abnormalities, and greater multimorbidity burden were consistently associated with adverse cardiorenal outcomes.
Therapeutic evidence from major randomized trials showed that sodium–glucose cotransporter-2 inhibitors significantly reduced major kidney and cardiovascular events across broad chronic kidney disease populations, while finerenone demonstrated complementary renal and cardiovascular benefits in patients with type 2 diabetes and chronic kidney disease.
The findings support a transition from isolated organ-based evaluation toward a multidimensional cardiorenal framework integrating renal function, cardiovascular status, metabolic disease, biomarker profiles, and therapeutic response.
Emerging biomarkers may improve biological phenotyping but should currently complement rather than replace established clinical variables.
Integrated, multidisciplinary management involving internal medicine, cardiology, and nephrology may provide a more coherent approach to risk stratification and individualized treatment in patients with complex cardiorenal disease.
Related Results
Multimorbidity and kidney health in old age : methodological considerations and longitudinal
Multimorbidity and kidney health in old age : methodological considerations and longitudinal
<p dir="ltr"><b>Introduction</b>: Multimorbidity (the presence of 22 chronic conditions in one individual) and chronic kidney disease (CKD) are increasingly commo...
Multimorbidity and kidney health in old age : methodological considerations and longitudinal associations
Multimorbidity and kidney health in old age : methodological considerations and longitudinal associations
<p dir="ltr"><b>Introduction</b>: Multimorbidity (the presence of ≥2 chronic conditions in one individual) and chronic kidney disease (CKD) are increasingly commo...
Multimorbidity, healthcare utilization, and quality of life for older patients undergoing surgery: A prospective study
Multimorbidity, healthcare utilization, and quality of life for older patients undergoing surgery: A prospective study
Multimorbidity (≥2 chronic illnesses) is a worldwide healthcare challenge. Patients with multimorbidity have a reduced quality of life and higher mortality than healthy patients an...
Journey to multimorbidity: longitudinal analysis exploring cardiovascular risk factors and sociodemographic determinants in an urban setting
Journey to multimorbidity: longitudinal analysis exploring cardiovascular risk factors and sociodemographic determinants in an urban setting
Objective
To study the social determinants and cardiovascular risk factors for multimorbidity and the acquisition sequence of multimorbidity.
...
Patterns of multimorbidity across obesity severity and fat distribution in Anhui, China: a community-based study
Patterns of multimorbidity across obesity severity and fat distribution in Anhui, China: a community-based study
IntroductionObesity and multimorbidity are prevalent worldwide. However, the relationships of obesity severity and fat distribution with multimorbidity patterns among the Chinese p...
A Machine Learning Approach to Prediction and Multimorbidity Risk Factor Identification in a low- and middle-income country
A Machine Learning Approach to Prediction and Multimorbidity Risk Factor Identification in a low- and middle-income country
Abstract
Importance
Multimorbidity, the coexistence of multiple chronic conditions, is a growing public health challenge, parti...
The association between multimorbidity and intrinsic capacity among older adults: The mediating role of frailty
The association between multimorbidity and intrinsic capacity among older adults: The mediating role of frailty
Abstract
Background
Intrinsic capacity(IC) proposed by the World Health Organization(WHO) is the core indicator of healthy aging, directly affecting functional abi...
Nurses' experience of managing adults living with multimorbidity: A qualitative study
Nurses' experience of managing adults living with multimorbidity: A qualitative study
Abstract
Background
The number of adults living with two or more chronic conditions is increasing worldwide. Adults livin...

